Abstract:You have accessJournal of UrologyBladder Cancer: Basic Research III1 Apr 20101144 CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC EFFECTS OF SILIBININ AGAINST SUPERFICIAL BLADDER CANCER BY ACTING ON MITOCHONDRIA Jin Zeng, Yi Sun, Kaijie Wu, Lei Li, and Dalin He Jin ZengJin Zeng , Yi SunYi Sun , Kaijie WuKaijie Wu , Lei LiLei Li , and Dalin HeDalin He View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.643AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Superficial bladder cancer accounts for approximately 70% of all bladder cancer cases. The standard treatment for patients with superficial bladder cancer is transurethral resection (TUR) of tumors. However, about 60-70% of these tumors will recur, with 25% showing progression to a higher stage or grade. Intravesical chemotherapy is often used to prevent recurrence and progression of superficial bladder cancer after transurethral resection. In preliminary studies, we observed the in vitro apoptotic effects of silibinin, a natural flavonoid, on human bladder carcinoma cells. Here, we further explore the mechanisms of its apoptosis regulation in bladder cancer and examined its intravesical efficacy on the prevention of bladder cancer. METHODS Human bladder carcinoma cell line 5637, which has the same molecular features of high-risk superficial bladder cancer, served as the model system in vitro and in vivo. Either cells or xenografts were analyzed for apoptosis molecular alterations after silibinin treatment. Autochthonous rat model of bladder cancer induced by intravesical N-methyl-N-nitrosourea (MNU) was used to investigate the intravesical efficacy of silibinin. RESULTS Exposure of 5637 cells to silibinin resulted in growth inhibition and induction of caspase-dependent and -independent apoptosis, which was associated with disruption of mitochondrial membrane potential and release of cytochrome c and AIF from mitochondria. Silibinin also down-regulated survivin and caused nuclear translocation of AIF. Consistently, oral silibinin suppressed the growth of 5637 xenografts which were accompanied with activation of caspase-3, downregulation of survivin and increased translocation of AIF. Furthermore, intravesical silibinin effectively inhibited bladder carcinogenesis in rats initiated by MNU by reducing the incidence of superficial and invasive bladder lesions which were accompanied with its proapoptotic effects. CONCLUSIONS These findings identify the in vitro and in vivo antitumor efficacy of silibinin, and suggest intravesical silibinin as an effective chemopreventive therapy for superficial bladder cancer. Table 1. Histopathological changes in SD rat bladders of different groups Group No. of rats sacrificed Normal(%) Hyperplasia, or atypia/dysplasia(%) Superficial bladder cancer(%) Muscle invasive bladder cancer(%) Control 10 10 0 0 0 MNU 24 0 9(37.5%) 9(37.5%) 6(25%) MNU+DMSO 23 0 8(35%) 10(43%) 5(22%) MNU+SB-200a 24 0 17(71%) 6(25%) 1(4%) MNU+SB-400a,b 23 2(9%) 17(74%) 4(17%) 0 SB-400 14 13(93%) 1(7%) 0 0 DMSO+saline 14 12(86%) 2(14%) 0 0 SB, silibinin. MNU, N-methyl-N-nitrosourea. a The observed differences for histopathological change in MNU+SB-200 and MNU+SB-400 groups versus the MNU group were statistically significant with P < 0.05. b Significantly different from the MNU+SB-200 group (P <0.05). Xi'an, People's Republic of China© 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e442-e443 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.Metrics Author Information Jin Zeng More articles by this author Yi Sun More articles by this author Kaijie Wu More articles by this author Lei Li More articles by this author Dalin He More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Effect of silibinin on proliferation of human bladder cancer cell 5637 in vitro and related mechanism

Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin Against Bladder Cancer by Acting on Mitochondria.

siRNA-mediated silencing of BC047440 gene inhibits proliferation of human HepG2 cell

Inhibitory Effect of Platycodin D on Human Colonic Cancer SW620 Cell Proliferation

Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer

Silibinin Inhibits Β-Catenin/zeb1 Signaling and Suppresses Bladder Cancer Metastasis Via Dual-Blocking Epithelial–mesenchymal Transition and Stemness

Role of Heat Shock Protein 70 in Silibinin-Induced Apoptosis in Bladder Cancer.

Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion

1144 CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC EFFECTS OF SILIBININ AGAINST SUPERFICIAL BLADDER CANCER BY ACTING ON MITOCHONDRIA

Silibinin induces apoptosis by caspase activation , down-regulating Bcl-2 and activating YAP / p 53 in renal cell carcinoma

Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification

Silibinin Inhibits Prostate Cancer Invasion, Motility and Migration by Suppressing Vimentin and MMP-2 Expression

Silencing of Mutant P53 by Sirna Induces Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells

Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells

Silibinin Inhibits Cell Growth and Induces Apoptosis by Caspase Activation, Down-Regulating Survivin and Blocking EGFR–ERK Activation in Renal Cell Carcinoma

Silibinin Induces Apoptosis Through Inhibition of the Mtor-Gli1-bcl2 Pathway in Renal Cell Carcinoma.

Silibinin-Induced Apoptosis and Downregulation of MicroRNA-21 and MicroRNA-155 in MCF-7 Human Breast Cancer Cells

Silibinin inhibits the stem cell property of renal cell carcinoma through Wnt/β-catenin signaling

Evaluation of Anti-Cancer Potency of Silibinin on Murine Renal Carcinoma RenCa Cells in an Animal Model with an Intact Immune System

Mp21-01 effects of silibinin against bladder cancer metastasis: roles of gsk3β/β-catenin/zeb1 signaling

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells